
Scientist, Downstream – Biologics Drug Substance Commercialization
Merck
Summary
We are seeking a motivated scientist/engineer to join our Bioprocess Drug Substance Commercialization group. This role offers an exciting opportunity to work on late-stage process development, technology transfer, and in-line support of biologics.
Job description
Responsibilities
- Lead the execution of hands-on experiments in biologics downstream processing, including lab-scale process characterization, pilot-scale process development, and process scale-up/scale-down model development
- Collaborate with commercial manufacturing teams as a process sciences representative to support facility start-up and in-line support activities, including on-the-floor support for drug substance manufacturing as needed
- Author and/or review technical documents to support Process Performance Qualification and licensure
Qualifications
- Bachelor's Degree or higher in Chemical Engineering, Chemistry, Biology or comparable discipline
- 2+ years of experience with downstream processing of monoclonal antibody (mAb) products or similar products in a laboratory or manufacturing setting, including unit operations such as membrane filtration, preparative chromatography, ultrafiltration or tangential flow filtration, and viral clearance
- Mechanistic understanding of downstream processing separation sciences
- Ability to execute experiments independently in a manner that meets quality and timeline expectations
- Well-developed communication, organizational, and problem-solving skills, with an attention to detail
Preferred
- Large molecule drug substance technology transfer experience
- Collaboration with analytical teams, pilot-scale, and/or manufacturing environments
- Experience authoring technical documentation in support of the following: process description, process characterization, process performance qualification, risk assessment, control strategy, process comparability reports, and/or regulatory submissions
- Current Good Manufacturing Practice (cGMP) awareness or experience
Requirements
- Bachelor's Degree or higher in Chemical Engineering, Chemistry, Biology or comparable discipline
- 2+ years of experience with downstream processing of monoclonal antibody (mAb) products or similar products in a laboratory or manufacturing setting
- Experience with unit operations such as membrane filtration, preparative chromatography, ultrafiltration or tangential flow filtration, and viral clearance
- Mechanistic understanding of downstream processing separation sciences
- Ability to execute experiments independently in a manner that meets quality and timeline expectations
- Well-developed communication, organizational, and problem-solving skills, with an attention to detail
- Large molecule drug substance technology transfer experience
- Collaboration with analytical teams, pilot-scale, and/or manufacturing environments
- Experience authoring technical documentation in support of process description, process characterization, process performance qualification, risk assessment, control strategy, process comparability reports, and/or regulatory submissions
- Current Good Manufacturing Practice (cGMP) awareness or experience
Benefits
- Medical, Dental & Vision
- Other Insurance Benefits
- 401(k) Retirement
- Paid Holidays
- Vacation
- Compassionate & Sick Days
- Annual Bonus
- Long-Term Incentive
Company overview
Merck & Co., Inc., known as Merck in the United States and Canada and MSD (Merck Sharp & Dohme) internationally, is a premier American multinational pharmaceutical company headquartered in Rahway, New Jersey. Founded in 1891 as the U.S. subsidiary of the German Merck Group, the company became independent following World War I and has since grown into one of the world's largest biomedical companies, ranking fourth globally by revenue. Merck operates across three core business segments: pharmaceuticals, vaccines, and animal health products. The company is renowned for its groundbreaking research and development, having brought numerous life-saving medicines to market including Keytruda (pembrolizumab), a leading immunotherapy for cancer treatment that generated $29.5 billion in 2024 revenue, and Gardasil, a revolutionary HPV vaccine. With approximately 75,000 employees worldwide, Merck maintains a robust pipeline of innovative therapies focused on oncology, vaccines, hospital acute care, cardiology, neuroscience, virology, immunology, and diabetes. The company invests heavily in R&D, spending $17.9 billion in 2024 alone, demonstrating its commitment to advancing scientific discovery. Merck's legacy spans over 130 years of bringing hope to humanity through important medicines and vaccines, operating with a purpose to use leading-edge science to save and improve lives globally while fostering an inclusive workforce and responsible business practices.